New York Times: May 4, 2019. Like all medical devices, breast implants concern patients who suffer as the FDA fails to adequately screen/monitor products.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
Breast Implants Tied to Rare Cancer to Remain on US Market
Associated Press: May 2, 2019. Though textured breast implants are tied to ALCL, a form of cancer, they’re allowed to stay on the markey by the FDA.
Read More »FDA Allows Breast Implants Linked to Rare Cancer to Remain on the Market
Philadelphia Inquirer: May 2, 2019. Despite their known link to cancer, the FDA lets textured breast implants stay on the market.
Read More »NCHR Letter Concerning Lead in DC Public School Playground
After lead was found in the playground at Janney Elementary School in Washington, DC, NCHR wrote a letter to DC Education Officials.
Read More »FDA Won’t Ban Breast Implants Linked to Cancer at This Time
Washington Post: May 2, 2019. The FDA finally almost acknowledges that women are getting sick from breast implants. Progress is too slowly being made.
Read More »